MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202637076975 A) filed by Novatim Immune Therapeutics Zhejiang on June 22, 2026, for Anti-Met/Egfr Bispecific Antibody And Drug Conjugate Thereof.
Inventors include Wu, Guoxiang; Cai, Xianghai; Hong, Yu; Jiang, Yingying Number; and Zhang, Chao.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: Provided is an anti-MET nanobody and an anti-EGFR nanobody, and a bispecific antibody comprising the two nanobodies. Also provided is a drug conjugate constructed on the basis of the nanobodies and the bispecific nanobody.
Disclaimer: Curated by HT Syndication.
